Mihai Folescu

Mihai Folescu

Auto-generated profile, based on publicly available information

Mihai Folescu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in Romanian Journal of Veterinary Sciences
Verified
Journal Article
Closed access
MDMaria Daia
Maria Daia
ADAlexandru Octavian Doma
Alexandru Octavian Doma
Romeo Teodor CRISTINARomeo Teodor CRISTINA
Romeo Teodor CRISTINA
EDEugenia Dumitrescu
Eugenia Dumitrescu
MFMihai Folescu
Mihai Folescu
Florin MuselinFlorin Muselin
Florin Muselin
Repeated and increased pesticide doses application have been observed in numerous countries, leading to their accumulation in food products. The study aimed to evaluate the behavior and residue levels of certain pesticides applied to parsley, green lettuce, and green onions. Four plots were used for each of the three vegetables studied: a control plot treated with distilled water, and three experimental plots—E1 with a normal concentration of 1%, E2 with double the concentration, and E3 with triple the concentration. Additionally, repeated sprayings were performed on days 1, 5, and 10. At the end of the application period, samples were collected and analyzed using gas chromatography-mass spectrometry (GC-MS). Results indicated that, after applying the standard dose of 1%, pesticide concentrations frequently exceeded reference limits (RL). For example, in parsley, abamectin levels increased by up to +433.33% over RL on the first day, and in the case of triple doses, the increase was over +1133%. Similarly, acetamiprid and deltamethrin showed significant increases, sometimes exceeding +4000%. In green lettuce and green onions, these values were also extremely high, reaching over +8000% for abamectin and acetamiprid. The tests also revealed that certain pesticides, such as azoxystrobin, had concentrations below the reference limits, indicating either a reduction in residues or that the applied doses were insufficient for detection. Analysis of differences based on the applied doses showed that, generally, increasing the pesticide dose results in proportional increases in residue levels. However, in some cases, concentration exceeded safety limits, posing risks to consumers. Significant fluctuations between different plots and harvest times were also observed, highlighting the importance of continuous monitoring and proper management of pesticide doses. The main conclusion is that applying pesticides at standard dosages can lead to residue levels above legal limits. Therefore, adherence to recommended practices and careful monitoring are essential to ensure food safety.

22 December 2025 in Romanian Journal of Veterinary Sciences
Verified
Journal Article
Closed access
MAMaria Larisa Ardelean
Maria Larisa Ardelean
Romeo Teodor CRISTINARomeo Teodor CRISTINA
Romeo Teodor CRISTINA
MFMihai Folescu
Mihai Folescu
Florin MuselinFlorin Muselin
Florin Muselin
ADAlexandru Octavian Doma
Alexandru Octavian Doma
EDEugenia Dumitrescu
Eugenia Dumitrescu
Silybum marianum L., a member of the Asteraceae family, is one of the most valuable medicinal plants, highly regarded for its abundance of bioactive compounds and diverse pharmacological applications. Native to the Mediterranean region, the species has spread globally, demonstrating remarkable ecological adaptability and resistance to unfavourable pedoclimatic conditions. The main phytochemical constituent, silymarin, is a complex of flavonolignans predominantly silibinin, isosilibinin, silychristin, and silydianin, which exhibit potent antioxidant, anti-inflammatory, and hepatoprotective properties. In addition to these compounds, the plant contains phenolic acids, flavonoids, unsaturated fatty acids, proteins, and fibres, all contributing to its high therapeutic and nutritional value. Silymarin acts by stabilising hepatocyte membranes, inhibiting toxin penetration, and stimulating cellular regeneration, while also exhibiting antidiabetic effects through enhanced insulin sensitivity and antitumoral activity via the induction of malignant cell apoptosis. Recent advances in modern extraction techniques and nanotechnological formulations have significantly improved the bioavailability and therapeutic efficacy of silymarin, supporting its clinical use. From an agronomic perspective, S. marianum is a sustainable species with low water and nutrient requirements, suitable for ecological cultivation systems. By integrating its therapeutic, biotechnological, and environmental value, Silybum marianum emerges as a model species with significant potential for research and phytotherapy in the 21st century.

30 June 2026 in Romanian Journal of Veterinary Sciences
Verified
Journal Article
Closed access
MAMaria Larisa Ardelean
Maria Larisa Ardelean
DCDaiana Ionela Cocoș
Daiana Ionela Cocoș
MFMihai Folescu
Mihai Folescu
Romeo Teodor CRISTINARomeo Teodor CRISTINA
Romeo Teodor CRISTINA
EDEugenia Dumitrescu
Eugenia Dumitrescu
Antimicrobial resistance continues to reduce the effectiveness of treatments in veterinary medicine and to increase the economic and health impact of infectious diseases in animals. Recent studies indicate that medicinal plants, essential oils, and other plant-derived compounds can exert antibacterial, antibiofilm, and sometimes synergistic effects with conventional antibiotics. In particular, the literature frequently focuses on pathogens such as Escherichia coli, Staphylococcus aureus, Salmonella spp., as well as bacteria involved in bovine mastitis and respiratory diseases of ruminants. However, direct comparison between studies remains difficult due to differences in extraction methods, phytochemical profiles, bacterial strains, and microbiological techniques. This narrative review synthesises recent evidence on the antibacterial activity of plant extracts relevant to veterinary medicine, with emphasis on the phytochemical classes involved, main veterinary applications, antibiofilm activity, and future directions of veterinary pharmacology based on natural products.

30 September 2026 in Romanian Journal of Veterinary Sciences
Verified
Journal Article
Closed access
MFMihai Folescu
Mihai Folescu
MAMaria Larisa Ardelean
Maria Larisa Ardelean
Florin MuselinFlorin Muselin
Florin Muselin
ADAlexandru Octavian Doma
Alexandru Octavian Doma
DCDaiana Ionela Cocoș
Daiana Ionela Cocoș
Romeo Teodor CRISTINARomeo Teodor CRISTINA
Romeo Teodor CRISTINA
The intestinal microbiota is a central regulator of mucosal and systemic immunity, and its disruption is strongly associated with chronic inflammatory disease. Probiotics defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host are increasingly used to modulate gut microbial communities and host immune responses. Experimental and clinical studies indicate that selected probiotic strains can reinforce barrier integrity, shape innate and adaptive immune cell function, and influence the production of immunoregulatory metabolites such as short-chain fatty acids. At the clinical level, probiotics show the most convincing benefit in specific settings, including induction and maintenance of remission in ulcerative colitis, prevention of antibiotic-associated diarrhea, and as adjuvant strategies in allergic and metabolic disease, although results remain heterogeneous across strains and indications. Here we synthesize current evidence on how probiotics influence gut-immune interactions, with a focus on mechanistic pathways linking microbial modulation to inflammation control and on the translational implications for immune-mediated diseases.

30 July 2025 in Romanian Journal of Veterinary Sciences
Verified
Journal Article
Closed access
MAMaria Larisa Ardelean
Maria Larisa Ardelean
LCLuminița Costinar
Luminița Costinar
MFMihai Folescu
Mihai Folescu
DCDaiana Ionela Cocoș
Daiana Ionela Cocoș
Romeo Teodor CRISTINARomeo Teodor CRISTINA
Romeo Teodor CRISTINA
EDEugenia Dumitrescu
Eugenia Dumitrescu
Coronaviruses are important pathogens responsible for respiratory and enteric diseases in mammals and birds. Among the identified coronaviruses, only six are known to infect humans: HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, SARS-CoV, and MERS-CoV. This study provides a global perspective on SARS-CoV-2 infections in animals, highlighting the species that are receptive and susceptible to this virus in the context of a potential future pandemic. We analyzed epidemiological data on the evolution of infections in both domestic and wild animals, considering the limited number of similar studies conducted in Romania. To obtain a comprehensive overview of the impact of SARS-CoV-2, we correlated data on the first cases of COVID-19 in humans with information on animal infections between 2020 and 2024. So far, SARS-CoV-2 has been detected in 35 animal species across 10 families and 4 orders (Carnivora, Artiodactyla, Primates, and Rodentia). In Europe, the number of confirmed cases in animals has been significant, totaling 18 242 infections during the analyzed period. Our study confirms interspecies transmission events from humans to animals, from animals to animals, and from animals to humans emphasizing the need for continued epidemiological research.

30 July 2025 in Romanian Journal of Veterinary Sciences
Verified
Journal Article
Closed access
Florin MuselinFlorin Muselin
Florin Muselin
ICIulia-Gabriela Colța
Iulia-Gabriela Colța
ADAlexandru Ocatvian Doma
Alexandru Ocatvian Doma
MFMihai Folescu
Mihai Folescu
DCDaiana Ionela Cocoș
Daiana Ionela Cocoș
Romeo Teodor CRISTINARomeo Teodor CRISTINA
Romeo Teodor CRISTINA
The potential therapeutic applications of cannabinoids have garnered the attention of human healthcare professionals, lead-ing to growing interest among pet owners regarding their use in veterinary medicine. Some cannabinoids found in oils have raised concerns about possible side effects, particularly hepatic issues with prolonged use. This preliminary study aimed to highlight changes in liver enzymes in dogs experiencing anxiety or pain treated with CBD oil over a three-month period. The study involved five dogs with various conditions, each administered 0.22 mg/kg of CBD twice daily for three months. Three of these dogs received additional "For liver" treatment one month after stopping CBD. The findings indicated that all dogs showed improvements in daily activity and mobility. However, liver enzyme levels increased in 3 out of 5 cases (with eleva-tions in AST and ALP), and one case showed an increase in gamma-glutamyl transferase (GGT), while alkaline phosphatase (ALP) rose in 4 out of 5 cases by the end of the treatment. These results of the preliminary study with limited sample size, suggest that CBD oil may affect the studied enzymes, indicating a potential hepatotoxic effect, particularly in older patients.